Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Sep 8, 2020 10:14 AM ET

Drug Screening Laboratory Services Market (COVID19- UPDATED) Tremendous Growth by 2025 | Abbott Laboratories (Alere Inc.), Acm Global Laboratories, Inc, Clinical Reference Laboratory


iCrowd Newswire - Sep 8, 2020

The ‘ Drug Screening Laboratory Services market’ research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market overview, Drug Screening Laboratory Services market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Drug Screening Laboratory Services market size forecast, market data & Graphs and Statistics, Tables, Bar &Pie Charts, and many more for business intelligence.

Download Free Sample Copy of ‘Drug Screening Laboratory Services market’ Report @

https://reportocean.com/industry-verticals/sample-request?report_id=AMR1093

Drug Screening Laboratory Services Market

The global drug screening laboratory services market was valued at $6,720.43 million in 2019, and is projected to reach $7,050.91 million by 2027, registering a CAGR of 9.4% from 2020 to 2027.

Drug screening is a quick and painless technical analysis of biological samples such as blood, hair, and urine to diagnose presence of illegal, prescription drugs, or its metabolites. Drug screening devices have improved, owing to the introduction of new technologies that offer users with precise and accurate results. Drug screening tests are adopted by employers to maintain a free, healthy, and sober workforce that helps maintain high productivity and an appropriate work environment. Rise in alcohol consumption among youth & elderly population, increase in use of narcotics & illicit drugs at workplace, and over use of prescribed drugs are the key factors that fuel growth of the drug screening laboratory services market. Moreover, technological advancements in drug screening products, surge in applications of these services, and increase in competition among providers boost growth of the global market. Furthermore, rise in government funding & initiatives for drug testing, increase in patient awareness toward drug screening policies, and adverse effects of drugs & alcohol are other factors that contribute toward growth of the market. However, possible manipulation of drug screening tests, and poor demand in under developed countries are expected to hinder growth of the market.

The drug screening laboratory services market is segmented into service type, sample type, end user, and region. On the basis of service, the market is categorized into workplace drug testing and clinical toxicology. By sample type, it is further divided into urine, oral fluid, breath, hair, and others. On the basis of end user, it is divided into retail, oil & gas, transportation, staffing, government, other workplaces, hospital laboratories, clinical laboratories, and other laboratories. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global drug screening laboratory services market along with the current trends and future estimations to elucidate the imminent investment pockets.

A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.

Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.

Extensive analysis of the key segments of the industry helps to understand the application and products of drug screening used across the globe.

Key market players and their strategies have been analysed to understand the competitive outlook of the drug screening laboratory services market.

KEY MARKET SEGMENTS

By Service Type

– Workplace Drug Testing

– Clinical Toxicology Testing

By Sample Type

– Urine Sample

– Oral Fluid Sample

– Hair Sample

– Others

By End User

– Retail

– Oil and Gas

– Transportation

– Staffing

– Government

– Other Workplaces

– Hospital Laboratories

– Clinical Laboratories

– Other Laboratories

KEY MARKET PLAYERS

– Abbott Laboratories (Alere Inc.)

– Acm Global Laboratories, Inc

– Clinical Reference Laboratory

– Quest Diagnostics Incorporated.

– Laboratory Corporation Of America Holdings

– Psychemedics

– Millennium Health

– Mayo Laboratories For Medical Education and Research

– Omega Laboratories

– Precision Diagnostics

– Cordant Health Solutions

 

Geographically, the following regions together with the listed national/local markets are fully investigated:
– APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
– Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
– North America (U.S., Canada, and Mexico)
– South America (Brazil, Columbia, Argentina, Rest of South America)
– MEA (Saudi Arabia, UAE, Egypt)

Impact of COVID-19 on the Global Market

The research report compiled by Report Ocean offers the study of market opportunities and market impact that are created due to the COVID-19 pandemic. The detailed research report is focused upon all direct and indirect impact of COVID-19 with new product launches, pipeline analysis, supply chain overview, government regulations, strategies adopted by related market players and upcoming vaccines and drug status. Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.(*If you have any special requirements, please let us know and we will offer you the report as you want.)

 (Check Our Exclusive Offer: Ask for Discount to our Representative)

https://reportocean.com/industry-verticals/sample-request?report_id=AMR1093

Furthermore, the years considered for the study are as follows:

Historical year – 2014-2019 | Base year – 2019 | Forecast period** – 2020 to 2025 [** unless otherwise stated]

Key questions answered: Study Explore COVID 19 Outbreak Impact Analysis

Ask Our Expert for Complete Report@:

https://reportocean.com/industry-verticals/sample-request?report_id=AMR1093

Key Points Covered in Drug Screening Laboratory Services Market Report: Study Explore COVID 19 Outbreak Impact Analysis

CHAPTER 1:INTRODUCTION

1.1.Report description

1.2.Key Benefits for Stakeholders

1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Porter;s five force analysis

3.3.Key findings

3.3.1.Top Investment Pockets

3.4.Regulations

3.5.Market share analysis

3.6.Market dynamics

3.6.1.Drivers

3.6.1.1.Stringent government regulations regarding drug abuse

3.6.1.2.Rise in awareness against drug abuse

3.6.1.3.Surge in funding for drug screening

3.6.2.Restraints

3.6.2.1.Consideration of drug screening as a violation of rights

3.6.2.2.Negative impact of COVID-19 pandemic on the drug screening market

3.6.3.Opportunities

3.6.3.1.Development of novel drug screening tests

3.6.3.2.Tapping emerging markets

3.7.COVID-19 impact on the market

CHAPTER 4:DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICE TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Workplace drug testing

4.2.1.Key market trends, growth factors, and opportunities

4.2.2.Market size and forecast, by region

4.2.3.Market analysis, by country

4.3.Clinical toxicology testing

4.3.1.Key market trends, growth factors, and opportunities

4.3.2.Market size and forecast, by region

4.3.3.Market analysis, by country

CHAPTER 5:DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Urine

5.2.1.Market size and forecast

5.2.2.Market analysis, by country

5.3.Oral fluid

5.3.1.Market size and forecast

5.3.2.Market analysis, by country

5.4.Hair

5.4.1.Market size and forecast

5.4.2.Market analysis, by country

5.5.Others

5.5.1.Market size and forecast

5.5.2.Market analysis, by country

CHAPTER 6:DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Retail

6.2.1.Market size and forecast

6.2.2.Market analysis, by country

6.3.Oil & gas

6.3.1.Market size and forecast

6.3.2.Market analysis, by country

6.4.Transportation

6.4.1.Market size and forecast

6.4.2.Market analysis, by country

6.5.Staffing

6.5.1.Market size and forecast

6.5.2.Market analysis, by country

6.6.Government

6.6.1.Market size and forecast

6.6.2.Market analysis, by country

6.7.Other workplaces

6.7.1.Market size and forecast

6.7.2.Market analysis, by country

6.8.Hospital laboratories

6.8.1.Market size and forecast

6.8.2.Market analysis, by country

6.9.Clinical laboratories

6.9.1.Market size and forecast

6.9.2.Market analysis, by country

6.10.Other laboratories

6.10.1.Market size and forecast

6.10.2.Market analysis, by country

CHAPTER 7:DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities

7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. drug screening laboratory services market, by services

7.2.2.1.2.U.S. drug screening laboratory services market, by sample type

7.2.2.1.3.U.S. drug screening laboratory services market, by end user

7.2.2.2.Canada

7.2.2.2.1.Canada drug screening laboratory services market, by services

7.2.2.2.2.Canada drug screening laboratory services market, by sample type

7.2.2.2.3.Canada drug screening laboratory services market, by end user

7.2.2.3.Mexico

7.2.2.3.1.Mexico drug screening laboratory services market, by services

7.2.2.3.2.Mexico drug screening laboratory services market, by sample type

7.2.2.3.3.Mexico drug screening laboratory services market, by end user

7.2.3.North America market size and forecast, by services

7.2.4.North America market size and forecast, by sample type

7.2.5.North America market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities

7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany drug screening laboratory services market, by services

7.3.2.1.2.Germany drug screening laboratory services market, by sample type

7.3.2.1.3.Germany drug screening laboratory services market, by end user

7.3.2.2.France

7.3.2.2.1.France drug screening laboratory services market, by services

7.3.2.2.2.France drug screening laboratory services market, by sample type

7.3.2.2.3.France drug screening laboratory services market, by end user

7.3.2.3.UK

7.3.2.3.1.UK drug screening laboratory services market, by services

7.3.2.3.2.UK drug screening laboratory services market, by sample type

7.3.2.3.3.UK drug screening laboratory services market, by end user

7.3.2.4.Italy

7.3.2.4.1.Italy drug screening laboratory services market, by services

7.3.2.4.2.Italy drug screening laboratory services market, by sample type

7.3.2.4.3.Italy drug screening laboratory services market, by end user

7.3.2.5.Spain

7.3.2.5.1.Spain drug screening laboratory services market, by services

7.3.2.5.2.Spain drug screening laboratory services market, by sample type

7.3.2.5.3.Spain drug screening laboratory services market, by end user

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe drug screening laboratory services market, by services

7.3.2.6.2.Rest of Europe drug screening laboratory services market, by sample type

7.3.2.6.3.Rest of Europe drug screening laboratory services market, by end user

 

7.3.3.Europe market size and forecast, by services

7.3.4.Europe market size and forecast, by sample type

7.3.5.Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities

7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan drug screening laboratory services market, BY SERVICES

7.4.2.1.2.Japan drug screening laboratory services market, by sample type

7.4.2.1.3.Japan drug screening laboratory services market, by end user

7.4.2.2.China

7.4.2.2.1.China drug screening laboratory services market, by services

7.4.2.2.2.China drug screening laboratory services market, by sample type

7.4.2.2.3.China drug screening laboratory services market, by end user

7.4.2.3.Australia

7.4.2.3.1.Australia drug screening laboratory services market, by services

7.4.2.3.2.Australia drug screening laboratory services market, by sample type

7.4.2.3.3.Australia drug screening laboratory services market, by end user

7.4.2.4.India

7.4.2.4.1.India drug screening laboratory services market, by services

7.4.2.4.2.India drug screening laboratory services market, by sample type

7.4.2.4.3.India drug screening laboratory services market, by end user

7.4.2.5.Rest of Asia-Pacific

7.4.2.5.1.Rest of Asia-Pacific drug screening laboratory services market, by services

7.4.2.5.2.Rest of Asia-Pacific drug screening laboratory services market, by sample type

7.4.2.5.3.Rest of Asia-Pacific drug screening laboratory services market, by end user

7.4.3.Asia-Pacific market size and forecast, by services

7.4.4.Asia-Pacific market size and forecast, by sample type

7.4.5.Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities

7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil drug screening laboratory services market, by services

7.5.2.1.2.Brazil drug screening laboratory services market, by sample type

7.5.2.1.3.Brazil drug screening laboratory services market, by end user

7.5.2.2.South Africa

7.5.2.2.1.South Africa drug screening laboratory services market, by services

7.5.2.2.2.South Africa drug screening laboratory services market, by sample type

7.5.2.2.3.South Africa drug screening laboratory services market, by end user

7.5.2.3.Saudi Arabia

7.5.2.3.1.Saudi Arabia drug screening laboratory services market, by services

7.5.2.3.2.Saudi Arabia drug screening laboratory services market, by sample type

7.5.2.3.3.Saudi Arabia drug screening laboratory services market, by end user

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA drug screening laboratory services market, by services

7.5.2.4.2.Rest of LAMEA drug screening laboratory services market, by sample type

7.5.2.4.3.Rest of LAMEA drug screening laboratory services market, by end user

7.5.3.LAMEA market size and forecast, by services

7.5.4.LAMEA market size and forecast, by sample type

7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES (ALERE)

8.1.1.Company overview

8.1.2.Company snapshot

8.1.3.Operating business segments

8.1.4.Business performance

8.2.QUEST DIAGNOSTICS INCORPORATED

8.2.1.Company overview

8.2.2.Company snapshot

8.2.3.Operating business segments

8.2.4.Business performance

8.3.CLINICAL REFERENCE LABORATORY, INC

8.3.1.Company overview

8.3.2.Company snapshot

8.4.LABORATORY CORPORATION OF AMERICA HOLDINGS

8.4.1.Company overview

8.4.2.Company snapshot

8.4.3.Operating business segments

8.4.4.Business performance

8.5.STERLING HEALTHCARE OPCO, LLC/CORDANT HEALTH SOLUTIONS

8.5.1.Company overview

8.5.2.Company snapshot

8.6.ACM GLOBAL LABORATORIES, INC

8.6.1.Company overview

8.6.2.Company snapshot

8.6.3.Key strategic moves and developments

8.7.OMEGA LABORATORIES LIMITED

8.7.1.Company overview

8.7.2.Company snapshot

8.8.PSYCHEMEDICS CORPORATION

8.8.1.Company overview

8.8.2.Company snapshot

8.8.3.Operating business segments

8.8.4.Business performance

8.8.5.Key strategic moves and developments

8.9.PRECISION DIAGNOSTICS

8.9.1.Company overview

8.9.2.Company snapshot

8.10.MILLENNIUM HEALTH

8.10.1.Company overview

8.10.2.Company snapshot

8.10.3.Key strategic moves and developments

8.11.MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH

8.11.1.Company overview

8.11.2.Company snapshot

 

……..and view more in complete table of Contents

 

Browse Premium Research Report with Tables and Figures at @ https://reportocean.com/industry-verticals/details?report_id=AMR1093

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.



Contact Information:

Get in Touch with Us:

Report Ocean

Email: sales@reportocean.com

Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES

Tel: +1 888 212 3539 (US – TOLL FREE)

Website: https://www.reportocean.com/

Blog: https://reportoceanblog.com/






Keywords:    Drug Screening Laboratory Services Market, Drug Screening Laboratory Services Market Analysis, Drug Screening Laboratory Services Market Growth, Drug Screening Laboratory Services Market Scope, Drug Screening Laboratory Services Market Share, Drug Screening Laboratory Services Market Trend, Drug Screening Laboratory Services Market Development, Drug Screening Laboratory Services Market Sales, Drug Screening Laboratory Services Market Forecast, Drug Screening Laboratory Services Market Opportunities, Drug Screening Laboratory Services Market Size

Tags:    IPS, Reportedtimes, iCN Internal Distribution, Research Newswire, English